Virtual Reality for Social Anxiety in Autism Spectrum Disorder
This study is looking at new ways to help adults with Autism Spectrum Disorder (ASD) and social anxiety. It compares two treatments: Cognitive Behavioral Therapy (CBT) with virtual reality (VR) social skills training, and CBT with "imaginal exposure" (using imagination to work through anxiety) and mindfulness. The goal is to see which treatment best reduces social anxiety, understand who benefits most from the VR approach, and see how well the VR intervention works. You might be able to join if you are an adult with ASD, are verbal and literate in English or Spanish, have average or higher intellectual ability, and can use a computer. The study aims to enroll 40 participants, but its current status is unclear.
- Study design
- This is an interventional study comparing two different treatment approaches for social anxiety in adults with autism. It plans to enroll 40 participants.
- What's involved
- You would receive 12 weeks of weekly CBT for social anxiety. Your anxiety levels will be measured at several points during treatment and about 4 weeks after treatment ends.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your anxiety levels will be assessed about 4 weeks after the end of treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Application of Virtual Reality Technology to Treatment of Social Anxiety
At a glance
Conditions
NCT06845488
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
The University of Texas Health Science Center at Houston
Houston, Texasstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Katherine Loveland, PhD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center at Houstom
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in anxiety as assessed by the Liebowitz Social Anxiety Scale (LSAS)Baseline, 3 weeks, 6 weeks, 9 weeks, 12 weeks, post treatment (about 4 weeks after end of treatment))
This is a 24 item questionnaire, each is assessed in 2 ways measuring both fear/anxiety and avoidance related to specific social situations, giving a total of 48 ratings across the scale. The questions are scored from 0 (none) to 3 (severe) for a score range of 0-144 higher score indicating worse outcome.
- Change in anxiety as assessed by the Social Interaction Anxiety Scale (SIAS)Baseline, 3 weeks, 6 weeks, 9 weeks, 12 weeks, post treatment (about 4 weeks after end of treatment)
This is a 20 item questionnaire and each is scored on a likert scale from 0(not at all characteristic of me)-4(Extremely characteristic of me), maximum score of 80,higher score indicating worse outcome
- Change in anxiety as assessed by the Social Phobia Scale (SPS)Baseline, 3 weeks, 6 weeks, 9 weeks, 12 weeks, post treatment (about 4 weeks after end of treatment)
This is a 20 item questionnaire and each is scored on a likert scale from 0-4, maximum score of 80 , higher score indicating worse outcome
- Change in anxiety as assessed by the The Severity Measure for Social Anxiety Disorder (SMSAD) scaleBaseline, 3 weeks, 6 weeks, 9 weeks, 12 weeks, post treatment (about 4 weeks after end of treatment)
This is a 10 item questionnaire and each is scored from 0(never) to 4(all of the time) for a maximum score of 40, higher score indicating worse outcome